Consolidated Statements of Changes in Stockholders’ (Deficit) Equity - USD ($) shares in Thousands, $ in Thousands	Total	Contingently Redeemable Convertible Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2021		10,826
Beginning balance at Dec. 31, 2021		$ 44,476
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of contingently redeemable preferred stock to common stock (in shares)		(10,826)
Conversion of contingently redeemable preferred stock to common stock		$ (44,476)
Ending balances (in shares) at Sep. 30, 2022		0
Ending balance at Sep. 30, 2022		$ 0
Beginning balance (in shares) at Dec. 31, 2021			271,576
Beginning balance at Dec. 31, 2021	$ 1,341,210		$ 27	$ 1,379,581	$ (27,432)	$ (10,966)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(1,711,471)				(1,711,471)
Other comprehensive income, net of income taxes	83,578					83,578
Stock-based compensation	165,949			165,949
Exercise of stock options (in shares)			1,321
Exercise of stock options	3,846			3,846
Restricted stock awards issued, net of shares withheld for tax withholding obligations (in shares)			39,099
Restricted stock awards issued, net of shares withheld for tax withholding obligations	(31,626)		$ 4	(31,630)
Restricted stock awards forfeited (in shares)			(2,268)
Exercise of convertible notes (in shares)			197
Exercise of convertible notes	1,574			1,574
Cashless exercise of warrants (in shares)			3,001
Issuances of common stock - equity line of credit (in shares)			7,315
Issuances of common stock - equity line of credit	13,040		$ 1	13,039
Conversion of contingently redeemable preferred stock to common stock (in shares)			10,826
Conversion of contingently redeemable preferred stock to common stock	44,476		$ 1	44,475
Issuances of common stock - Merger with XPDI (in shares)			30,778
Issuances of common stock - Merger with XPDI	163,459		$ 3	163,456
Issuances of common stock - financing transaction fees (in shares)			1,285
Issuances of common stock - financing transaction fees	2,960			2,960
Issuances of common stock - vendor settlement (in shares)			1,580
Issuances of common stock - vendor settlement	12,674			12,674
Costs attributable to issuance of common stock and equity instruments - Merger with XPDI	(16,642)			(16,642)
Ending balance (in shares) at Sep. 30, 2022			364,710
Ending balance at Sep. 30, 2022	73,027		$ 36	1,739,282	(1,738,903)	72,612
Ending balances (in shares) at Sep. 30, 2022		0
Ending balance at Sep. 30, 2022		$ 0
Beginning balance (in shares) at Jun. 30, 2022			353,481
Beginning balance at Jun. 30, 2022	416,452		$ 35	1,695,748	(1,304,111)	24,780
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(434,792)				(434,792)
Other comprehensive income, net of income taxes	47,832					47,832
Stock-based compensation	29,884			29,884
Restricted stock awards issued, net of shares withheld for tax withholding obligations (in shares)			4,897
Restricted stock awards issued, net of shares withheld for tax withholding obligations	(2,349)			(2,349)
Restricted stock awards forfeited (in shares)			(2,268)
Issuances of common stock - equity line of credit (in shares)			7,315
Issuances of common stock - equity line of credit	13,040		$ 1	13,039
Issuances of common stock - financing transaction fees (in shares)			1,285
Issuances of common stock - financing transaction fees	2,960			2,960
Ending balance (in shares) at Sep. 30, 2022			364,710
Ending balance at Sep. 30, 2022	$ 73,027		$ 36	1,739,282	(1,738,903)	$ 72,612
Beginning balance (in shares) at Dec. 31, 2022	375,225		375,225
Beginning balance at Dec. 31, 2022	$ (409,346)		$ 36	1,764,368	(2,173,750)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(388)				(388)
Ending balance at Mar. 31, 2023	$ (397,461)				(2,174,138)
Beginning balance (in shares) at Dec. 31, 2022	375,225		375,225
Beginning balance at Dec. 31, 2022	$ (409,346)		$ 36	1,764,368	(2,173,750)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(50,794)				(50,794)
Other comprehensive income, net of income taxes	0
Stock-based compensation	$ 41,414			41,414
Restricted stock awards issued, net of shares withheld for tax withholding obligations (in shares)			11,020
Restricted stock awards forfeited (in shares)			(377)
Ending balance (in shares) at Sep. 30, 2023	385,868		385,868
Ending balance at Sep. 30, 2023	$ (418,726)		$ 36	1,805,782	(2,224,544)
Beginning balance (in shares) at Jun. 30, 2023			379,091
Beginning balance at Jun. 30, 2023	(392,441)		$ 36	1,790,921	(2,183,398)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(41,146)				(41,146)
Other comprehensive income, net of income taxes	0
Stock-based compensation	$ 14,861			14,861
Restricted stock awards issued, net of shares withheld for tax withholding obligations (in shares)			7,154
Restricted stock awards forfeited (in shares)			(377)
Ending balance (in shares) at Sep. 30, 2023	385,868		385,868
Ending balance at Sep. 30, 2023	$ (418,726)		$ 36	$ 1,805,782	$ (2,224,544)